Three sensitive assays (Behring, Organon and LKB-Pharmacia) for measurement of serum thyrotropin (TSH) were evaluated. All three assays showed good precision, sensitivity, linearity and for practical purposes negligible high dose hook effects. The correlations between the assays were excellent, but due to standardisation and/or matrix effects there were incomplete recoveries in two kits and the kits showed systematic differences of up to 20% in the TSH values obtained.
SAMPLES AND CONTROL SERA
Serum samples from all subjects and serum pools containing high (range 5-27 ml.I/L) and undetectably low concentrations of TSH were, after collection, stored in aliquots at -18°C.
The human TSH reference preparations (WHO 1 st IRP (MRC: 68/38) and WHO 2 nd IRP (MRC: 80/558» were obtained from the National Institute for Biological Standards and Control, London, UK. Monoclonal antibodies have made it possible to develop specific and sensitive immunoassays for measuring thyrotropin (thyroid stimulating hormone, TSH).1-3Various procedures have become commercially available differing in the choice of antibody, label and separation method."! We report here an analytical and clinical evaluation of three such sensitive TSH assays. The clinical performances ofthese kits were tested by measuring the serum concentration of TSH in patients with thyroid illness, and in euthyroid subjects with thyroxine-binding abnormalities and patients with severe non-thyroidal illness in whom the usual thyroid function tests are often unsatisfactory.
Materials and methods

SUBJECTS
The clinical performance of the assays was studied in 188 subjects. Most of them were outpatients except for the patients with non-thyroidal illness who came from the intensive care unit. The classification of the patients into the different groups was based mainly on clinical assessment, supported by thyroid hormone measurements.
The following groups of subjects were tested: I: 20 Purified human TSH was obtained from Sigma Chemical Company (St Louis, MO, USA). Trilevel ligand assay control (Gilford; Irvine, CA, USA) and Lyphocheck immunoassay control sera (Biorad; Anaheim, CA, USA) were used as lyophilized control sera. ASSAYS All assays were performed according to the protocols recommended by the manufacturers. Table I shows the principal characteristics of the three sensitive TSH kits that were evaluated.
Procedures and results
SENSITIVITY
The lower detection limit was determined by replicate analysis (n = 20) of the zero standard. It was defined as the TSH concentration at the response of the mean +2SD response of the zero standard." We found 0·03 ml.l/L for the Behring and 0·02 mUlL for the Organon and LKB kits. These differences are not significant. LINEARITY Linearity was evaluated by two different parallellism studies:" serial dilutions of a serum sample containing high concentration of TSH with: (a) serum containing undetectably low concentration of TSH; (b) the zero standards of the kits. According to our dilution experiments all three assays showed linear dilution curves in the concentration range used (0-25 mUlL TSH).
RECOVERY
The analytical recoveries of the kits were estimated by:" (a) Serial dilutions of MRC 80/558 (for the Behring, LKB and Organon kits) and MRC 68/38 (for the Organon kit) in serum with a TSH concentration below the detection limit. (b) Addition of kit standards in dilutions of I :2
to serum with a TSH concentration below the detection limit. The results are summarised in Table 2 . PRECISION Inter-assay precision was estimated by measuring control sera at three levels. The control sera used were Gilford ligand assay sera for the Behring and Organon kits and Lyphochek for the LKB assay. The results are shown in Table 3 . Intra-assay precision was estimated by calculating the imprecision-profiles of the assays according to Channing Rodgers. II They are shown in 
Discussion
ANALYTICAL PERFORMANCE
The new immunometric assays based upon monoclonal antibodies herald a new era in thyroid diagnosis." At the same time new technical problems have been generated by the highly sensitive nature of these assays," 15 e.g. production of an acceptable TSH-free matrix for standards, standardisation, etc. We investigated several aspects of three sensitive TSH assays routinely in use in three hospital laboratories in our region in order to determine possible laboratory-dependent effects which could affect comparability of results. The working ranges are wide enough for clinical use; the LKB kit with a standard range up to 324 mU/L is possibly more convenient from a practical point of view. The assays are sufficiently precise in the clinically important range.
The imprecision-profile shows excellent precision for the LKB assay over the whole standard range of 0·25-324 ml.J/L. We confirmed the previous observations ofCV < 5% for inter-and intra-assay precision.P-" Since the theoretical analytical goal for TSH in the normal range is a CV < 8·1%,18 this is an outstanding performance. In accordance with others," we found rather poorer precision for the other two kits near the lower normal limits. On the other hand, the The clinical utility of the assays was investigated in patient groups I-IX (groups X and XI were only used for correlation studies) by comparing the clinical classification with the expected values suggested by the manufacturers. Of the 474 results 31 showed a discrepancy (6 with Behring, 13 with Organon and 12 with LKB) between the values found and the values that can be expected according to the clinical classification ( Fig. 4 ).
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CORRELA TION
Orthogonal regression analysis was carried out for all serum samples with TSH concentration < 50 mUlL. The results are shown in Fig. 3 . Samples with TSH concentration < 5 mUlL are plotted separately for clarity.
High dose hook effects were observed at concentrations of 400, 550 and 2500 mUlL for the Behring, Organon and LKB kit, respectively. Concentrations which give values below those of the highest standard of the kits were found at 1100, 8000 and > 13000 mU/L for the Behring, Organon and LKB kit, respectively ( diagnostic performances of these assays are good in this low range. This is reflected in the fact that the overlap between the TSH values of euthyroid and hyperthyroid subjects is very small. IS In addition, all three assays showed linear dilution curves. High dose hook effects are not clinically important.
Our results for the regression between the three assays and the analytical recovery clearly indicate one of the technical difficulties in working with TSH immunoassays. The correlation coefficients of 0,98-0·99 appeared not to be significantly influenced by the many values below the detection limit ( Fig. 3) . However, the regression equations indicate systematic differences of up to 20% between the kits.
We found a possible explanation for this finding by checking the standardisation of the kits in several experiments. We measured the recoveries of the MRC-standards on which the kits were calibrated (Table I) .
The results (Table 2a) show marked deviations from the expected 100%. The finding of system atic differences of about 25% in the Behring kit!' and the LKB kit 6 • 16 , 17 has been noted by others.
The deviation of +25% in the Organon-kit cannot be attributed to the use of a different MRC-standard, since MRC 80/558 gave a comparable result (Table 2a ). This indicates that even if the kits were standardised on the same IRP, significant differences would remain. The same differences can be seen when comparing the 'expected values' of the three kits (Table I) , resulting in a comparable classification of patients.
For the Organon and LKB kits we found the expected recoveries with the own standards of the kit, but with the Behring kit these were remarkably low (Table 2b ). This suggests a difference in matrix between serum and standard. The effect is even more marked when the MRC standard is added to the zero standard: recovery is only 48% (Table 2c) . We can only speculate about the explanation since the composition of the standard matrix is confidential. The only practical consequence is that the zero standard is not to be used as a diluent for serum samples.
However, our general conclusion is that the kits are simple in use and the results reproducible. All three assays meet the analytical requirements for a suitable TSH estimation.
Clinical performance
Measurement of the TSH level in serum is one of the essential tests of thyroid function.'? Unfortunately, previous immunoassays for TSH were unsuitable to differentiate between normal and pathological TSH values in the low concentration range because of their limited sensitivity.'? The main advantage of the immunometric assays is their improved analytical sensitivity which : The results in 20 euthyroid subjects (group I) shown in the scatter diagrams ( Fig. 4) suggest that the upper limits as given by the manufacturers are slightly too low. The number of observations, however, is too small for definitive statistical conclusions. This difference is no reason to depart from these reference values for the classifications in the patient studies and hardly influences our conclusions.
In a group of 20 hyperthyroid patients (group III) only one patient had borderline TSH values in two kits. In the other patients the TSH levels measured were clearly below the lower limit of the reference interval.
In all clinically hypothyroid patients (group II) the measured values were above the reference values.
TSH levels in pregnant women (group IV) showed no deviation from the reference interval. Although there still is some discussion about thyroid function during late pregnancy, we cannot confirm the observations of Hara et al. 20 about the low TSH in pregnancy and we conclude in accordance with others8.21.22 that the TSH level is normal in late pregnancy and reflects the euthyroid state of these subjects.
The same holds true for subjects with abnormalities in their binding proteins like congenital thyroxine-binding globulin deficiency, familial dysalbuminemic hyperthyroxinemia, congenital analbuminemia and subjects with slight deviations of TBG levels induced by oral contraceptives. The TSH levels in these groups ( Fig. 4 . groups V, VI, VII and IX) showed no deviation from the reference interval.
A remarkable deviation from the reference values is seen in the group of intensive care patients (group VIII). This is in agreement with the literature and shows that alterations in thyroid function tests are extremely frequent in euthyroid patients with acute systemic illness." Recent reports concerning sensitive assays to measure serum TSH in these patients are contradictory. Some state that the 'low TSH syndrome' might be characteristic for the 'euthyroid sick syndrome 22,24-26 others claim the same interpretation of TSH results in patients with or without non-thyroidal illness." Furthermore, it has been demonstrated in longitudinal studies that TSH concentrations can change markedly from decreased to increased during the different phases of systemic illness. 28 ,29 This could be an explanation for the scatter of the results in our non-thyroidal illness group because this group was not homogeneous as far as the severity and the phase of the systemic illness were concerned. In addition it has been suggested'? that use of dopamine or dopamine agonists has a inhibitory effect on TSH release. We can not confirm this because in our patient group there were only three patients treated with dopamine. These patients did not show low TSH values.
In conclusion, our data show that all three assays are suitable for clinical use. Although standardisation does not meet the goal of the WHO when defining the TSH unit on basis of the IRP, and a lot of work remains to be done in this field for scientific purposes, we think the three assays evaluated here yield essentially the same results in classifying the patients in the diagnostic categories.
Therefore, all three kits are reliable in a routine laboratory for the evaluation of the thyroid status, particularly in subjects with abnormalities in their binding proteins.
